Marathon Asset Management LLP Buys 12,126 Shares of Globus Medical Inc (GMED)

Marathon Asset Management LLP boosted its stake in shares of Globus Medical Inc (NYSE:GMED) by 1.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 771,826 shares of the medical device company’s stock after acquiring an additional 12,126 shares during the quarter. Marathon Asset Management LLP owned about 0.80% of Globus Medical worth $31,722,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of GMED. Goldman Sachs Group Inc. lifted its holdings in shares of Globus Medical by 26.2% in the 2nd quarter. Goldman Sachs Group Inc. now owns 166,090 shares of the medical device company’s stock valued at $5,505,000 after buying an additional 34,513 shares during the period. Retirement Systems of Alabama lifted its holdings in shares of Globus Medical by 45.6% in the 3rd quarter. Retirement Systems of Alabama now owns 135,562 shares of the medical device company’s stock valued at $4,029,000 after buying an additional 42,481 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Globus Medical by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 5,712,043 shares of the medical device company’s stock valued at $189,355,000 after buying an additional 76,345 shares during the period. Rhumbline Advisers lifted its holdings in shares of Globus Medical by 7.4% in the 3rd quarter. Rhumbline Advisers now owns 154,127 shares of the medical device company’s stock valued at $4,581,000 after buying an additional 10,679 shares during the period. Finally, AJO LP acquired a new stake in shares of Globus Medical in the 2nd quarter valued at approximately $1,262,000. 70.24% of the stock is owned by institutional investors.

Globus Medical Inc (NYSE GMED) opened at $43.28 on Thursday. Globus Medical Inc has a one year low of $25.67 and a one year high of $46.51. The firm has a market capitalization of $4,141.28, a P/E ratio of 39.35, a P/E/G ratio of 2.66 and a beta of 0.56.

Globus Medical (NYSE:GMED) last released its quarterly earnings data on Wednesday, November 8th. The medical device company reported $0.30 earnings per share for the quarter, meeting the consensus estimate of $0.30. Globus Medical had a return on equity of 13.67% and a net margin of 17.54%. The firm had revenue of $151.74 million during the quarter, compared to the consensus estimate of $150.73 million. During the same period last year, the business posted $0.29 EPS. Globus Medical’s quarterly revenue was up 11.9% on a year-over-year basis. analysts predict that Globus Medical Inc will post 1.27 EPS for the current year.

Several analysts have recently commented on GMED shares. BidaskClub raised Globus Medical from a “hold” rating to a “buy” rating in a report on Tuesday, November 14th. Bank of America raised Globus Medical from an “underperform” rating to a “neutral” rating in a report on Friday, November 10th. Zacks Investment Research raised Globus Medical from a “sell” rating to a “hold” rating in a report on Wednesday, January 10th. ValuEngine cut Globus Medical from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Finally, BTIG Research reissued a “buy” rating and issued a $37.00 price target on shares of Globus Medical in a report on Thursday, November 9th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $40.57.

In other Globus Medical news, CAO Steven Payne sold 3,076 shares of the firm’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $39.30, for a total transaction of $120,886.80. Following the completion of the transaction, the chief accounting officer now owns 23,847 shares of the company’s stock, valued at $937,187.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, President Anthony L. Williams sold 15,000 shares of the firm’s stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $38.30, for a total value of $574,500.00. Following the transaction, the president now directly owns 15,000 shares of the company’s stock, valued at approximately $574,500. The disclosure for this sale can be found here. Insiders sold a total of 124,908 shares of company stock valued at $4,747,975 over the last ninety days. 28.21% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY WARNING: “Marathon Asset Management LLP Buys 12,126 Shares of Globus Medical Inc (GMED)” was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at https://stocknewstimes.com/2018/01/18/marathon-asset-management-llp-buys-12126-shares-of-globus-medical-inc-gmed.html.

Globus Medical Profile

Globus Medical, Inc (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company’s products fall into one of two categories: Innovative Fusion or Disruptive Technologies.

Want to see what other hedge funds are holding GMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globus Medical Inc (NYSE:GMED).

Institutional Ownership by Quarter for Globus Medical (NYSE:GMED)

Receive News & Ratings for Globus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply